Tianjin Tianyao Pharmaceuticals Co Ltd Financial Flexibility Index
Tianjin Tianyao Pharmaceuticals Co Ltd financial flexibility index. Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥30.67 Million (operating CF CN¥13.19 Million minus capex CN¥17.49 Million) represents 0% of total liabilities (CN¥1.85 Billion). See 600488 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Financial flexibility index of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. Historical Financial Flexibility Index trend for Tianjin Tianyao Pharmaceuticals Co Ltd across 25 annual periods. Check earnings quality score of Tianjin Tianyao Pharmaceuticals Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Tianjin Tianyao Pharmaceuticals Co Ltd Financial Flexibility Index by Year (2000–2024)
Tianjin Tianyao Pharmaceuticals Co Ltd financial flexibility index by year from 2000 to 2024. Year-by-year free cash flow to debt coverage for Tianjin Tianyao Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see 600488 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | CN¥647.11 Million | CN¥569.37 Million | CN¥1.81 Billion | ▼ -6.9% |
| 2023 | 0.38x | CN¥916.16 Million | CN¥783.01 Million | CN¥2.39 Billion | ▲ +29.8% |
| 2022 | 0.30x | CN¥855.72 Million | CN¥653.52 Million | CN¥2.90 Billion | ▲ +8.6% |
| 2021 | 0.27x | CN¥687.73 Million | CN¥316.89 Million | CN¥2.53 Billion | ▼ -18.8% |
| 2020 | 0.34x | CN¥805.40 Million | CN¥346.88 Million | CN¥2.40 Billion | ▲ +1.7% |
| 2019 | 0.33x | CN¥558.41 Million | CN¥279.37 Million | CN¥1.70 Billion | ▲ +27.3% |
| 2018 | 0.26x | CN¥392.85 Million | CN¥189.27 Million | CN¥1.52 Billion | ▲ +165.5% |
| 2017 | 0.10x | CN¥112.45 Million | CN¥-8.15 Million | CN¥1.15 Billion | ▼ -61.1% |
| 2016 | 0.25x | CN¥128.10 Million | CN¥63.32 Million | CN¥511.21 Million | ▼ -16.2% |
| 2015 | 0.30x | CN¥174.83 Million | CN¥129.50 Million | CN¥584.42 Million | ▼ -23.3% |
| 2014 | 0.39x | CN¥195.54 Million | CN¥178.76 Million | CN¥501.34 Million | ▼ -22.3% |
| 2013 | 0.50x | CN¥394.63 Million | CN¥84.55 Million | CN¥785.64 Million | ▲ +309.5% |
| 2012 | 0.12x | CN¥88.82 Million | CN¥13.23 Million | CN¥724.13 Million | ▼ -36.6% |
| 2011 | 0.19x | CN¥141.24 Million | CN¥78.47 Million | CN¥729.86 Million | ▼ -5.8% |
| 2010 | 0.21x | CN¥264.58 Million | CN¥116.82 Million | CN¥1.29 Billion | ▼ -65.6% |
| 2009 | 0.60x | CN¥637.45 Million | CN¥435.13 Million | CN¥1.07 Billion | ▲ +10.5% |
| 2008 | 0.54x | CN¥576.94 Million | CN¥219.31 Million | CN¥1.07 Billion | ▲ +19.3% |
| 2007 | 0.45x | CN¥387.07 Million | CN¥162.33 Million | CN¥854.65 Million | ▲ +401.9% |
| 2006 | 0.09x | CN¥121.63 Million | CN¥50.72 Million | CN¥1.35 Billion | ▲ +78.0% |
| 2005 | 0.05x | CN¥47.32 Million | CN¥-108.87 Million | CN¥933.43 Million | ▼ -88.7% |
| 2004 | 0.45x | CN¥243.77 Million | CN¥110.30 Million | CN¥541.10 Million | ▲ +37.0% |
| 2003 | 0.33x | CN¥220.01 Million | CN¥45.77 Million | CN¥669.25 Million | ▼ -3.6% |
| 2002 | 0.34x | CN¥216.48 Million | CN¥45.28 Million | CN¥634.50 Million | ▲ +18.8% |
| 2001 | 0.29x | CN¥120.44 Million | CN¥71.87 Million | CN¥419.39 Million | ▲ +8.1% |
| 2000 | 0.27x | CN¥77.35 Million | CN¥41.06 Million | CN¥291.03 Million | — |